Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP3 | P08254 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
| ▸ | PRKCA | P17252 | 4/20 | 0.42 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | CTSK | P43235 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28711682 | 0.87 | MMP1 (0.52) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL28184364 | 0.87 | MAPT (0.43) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL5907616 | 0.86 | PRKCA (0.41) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL20132836 | 0.84 | PRKCA (0.42) | PRKCAPRKCDMAPTMAPK1ALDH1A1 | |
| SCHEMBL17878539 | 0.82 | MAPT (0.42) | PRKCAPRKCDMAPTMAPK1ALDH1A1 | |
| SCHEMBL5534325 | 0.81 | PRKCA (0.46) | PRKCAPRKCDMAPTMAPK1ALDH1A1 | |
| SCHEMBL3793162 | 0.81 | PRKCA (0.46) | PRKCAPRKCDMAPTMAPK1ALDH1A1 | |
| SCHEMBL18485858 | 0.80 | MMP1 (0.50) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL22644005 | 0.79 | PRKCA (0.35) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL4347723 | 0.79 | ALDH1A1 (0.46) | PRKCAPRKCDMAPTMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4433045-A2 | FORMULATIONS AND METHODS FOR TREATING SYMPTOMS OF MENOPAUSE | KINDRA CORPORATION (US) | 2024-09-25 | — | — | EP | disclosed |
| WO-2023288050-A9 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2023091628-A2 | FORMULATIONS AND METHODS FOR TREATING SYMPTOMS OF MENOPAUSE | PG13 LAUNCHPAD ALPHA, INC. DBA KINDRA (US) | 2023-05-25 | — | — | WO | disclosed |